GI DYNAMICS, INC - Announcements

0.00%

0.2¢

Currently unlisted.

GI Dynamics, Inc. is a medical device company. The Company designs and applies device and... GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

GID	Association of British Clinical Diabetologists Funds Study	PRICE SENSITIVE	09/09/13	103.49KB	Share
GID	Half Yearly Report and Accounts	PRICE SENSITIVE	30/08/13	215.19KB	Share
GID	Information disclosed under ASX Listing Rule 3.10.5A		30/08/13	34KB	Share
GID	Release of Securities from ASX Escrow		22/08/13	31.51KB	Share
GID	Change in substantial holding		14/08/13	81.3KB	Share
GID	Ceasing to be a substantial holder		13/08/13	50.31KB	Share
GID	Change in substantial holding		13/08/13	50.45KB	Share
GID	Change in substantial holding		13/08/13	50.67KB	Share
GID	Change in substantial holding		13/08/13	52.38KB	Share
GID	Change in substantial holding		13/08/13	53.97KB	Share
GID	Cleansing Notice		09/08/13	504.24KB	Share
GID	Appendix 3B		09/08/13	168.6KB	Share
GID	GI Dynamics to Present at Canaccord Genuity Conference		08/08/13	54.86KB	Share
GID	Change of Director's Interest Notice		07/08/13	74.54KB	Share
GID	Change of Director's Interest Notice		07/08/13	74.55KB	Share
GID	Appendix 3B		07/08/13	225.73KB	Share
GID	Form604 Notice of change of interests of substantial holder		06/08/13	38.81KB	Share
GID	Results of Meeting		01/08/13	168.92KB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/13	168.6KB	Share
GID	Special Meeting of Stockholders Conference Call		24/07/13	44.92KB	Share
GID	Security Purchase Plan		12/07/13	626.31KB	Share
GID	Notice of Extraordinary General Meeting/Proxy Form		12/07/13	437.49KB	Share
GID	Becoming a substantial holder		12/07/13	145.11KB	Share
GID	Appendix 3B		11/07/13	188.34KB	Share
GID	Form604 Notice of change of interests of substantial holder		11/07/13	77.29KB	Share
GID	Cleansing Notice		10/07/13	83.54KB	Share
GID	Details of Company Address		05/07/13	48.96KB	Share
GID	GI Dynamics Investor Presentation		03/07/13	1.62MB	Share
GID	GI Dynamics Completes A$57.5 MIillion Private Placement	PRICE SENSITIVE	03/07/13	105.29KB	Share
GID	Trading Halt	PRICE SENSITIVE	01/07/13	485.72KB	Share
GID	GI Dynamics, Inc. Appoints Distributor for the Middle East	PRICE SENSITIVE	26/06/13	75.81KB	Share
GID	French Government Approves and Funds Two-Year Clinical Study	PRICE SENSITIVE	19/06/13	79.84KB	Share
GID	New Commercial Centres in the European Union	PRICE SENSITIVE	18/06/13	80.18KB	Share
GID	Appendix 3B	PRICE SENSITIVE	06/06/13	172.12KB	Share
GID	Results of Meeting		20/05/13	139.65KB	Share
GID	Annual General Meeting Presentation and Webcast		20/05/13	1.53MB	Share
GID	2013 Annual General Meeting Webcast/Conference Call		14/05/13	89.98KB	Share
GID	GI Dynamics names David Maggs, M.D. as Chief Medical Officer		01/05/13	339.04KB	Share
GID	Notice of Annual Meeting/Proxy Form		30/04/13	1.14MB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/13	157.3KB	Share
GID	Change in substantial holding		26/04/13	85.57KB	Share
GID	GI Dynamics, Inc. Reports on Progress of the ENDO Trial	PRICE SENSITIVE	26/04/13	80.18KB	Share
GID	Appendix 3B		12/04/13	215.95KB	Share
GID	Annual Report to shareholders		28/03/13	1.66MB	Share
GID	Details of Company Address		28/03/13	38.2KB	Share
GID	Change of Directors Interest Notice		19/03/13	77.14KB	Share
GID	Appendix 3B		19/03/13	164.59KB	Share
GID	EndoBarrier Named Product of the Year by BioSpectrum Asia		18/03/13	45.07KB	Share
GID	Change of Director's Interest Notice		12/03/13	77.88KB	Share
GID	Change of Director's Interest Notice		12/03/13	76.18KB	Share
GID	CMS Medical to Distribute EndoBarrier Therapy in Brazil		06/03/13	72.54KB	Share
GID	Preliminary Final Report	PRICE SENSITIVE	28/02/13	568.96KB	Share
GID	Commercial Availability of EndoBarrier Therapy in Israel	PRICE SENSITIVE	27/02/13	97.93KB	Share
GID	GI Dynamics to Present at the Cowen Healthcare Conference		27/02/13	30.53KB	Share
GID	Change of Director's Interest Notice		26/02/13	76.08KB	Share
GID	Change of Director's Interest Notice		26/02/13	77.71KB	Share
GID	Briefing Call and Webcast on Financial Results for 2012		20/02/13	66.98KB	Share
GID	Release of Securities from Voluntary Escrow		19/02/13	88.34KB	Share
GID	EndoBarrier Therapy effect on mildly obese patients	PRICE SENSITIVE	01/02/13	124.31KB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/13	196.75KB	Share
GID	Appendix 3B		18/01/13	232.07KB	Share
GID	U.S. Pivotal Clinical Trial of EndoBarrier Initiated	PRICE SENSITIVE	15/01/13	128.74KB	Share
GID	GI Dynamics Announces Resolution of Litigation with Gore	PRICE SENSITIVE	10/01/13	128.29KB	Share
GID	GI Dynamics Announces Research Collaborations	PRICE SENSITIVE	04/01/13	104.93KB	Share
GID	Change of Director's Interest Notice		19/12/12	74.73KB	Share
GID	Form604 Notice of Change of interests of substantial holder		03/12/12	62.43KB	Share
GID	Release of Securities from Voluntary Escrow		27/11/12	88.18KB	Share
GID	Appendix 3B		22/11/12	233.78KB	Share
GID	GID to Present at Lazard and Canaccord Hlthcare Conferences		07/11/12	107.65KB	Share
GID	Form604 Notice of change of interests of substantial holder		02/11/12	71.02KB	Share
GID	Form604 Notice of change of Interests of substantial holder		01/11/12	70.58KB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/12	231.68KB	Share
GID	Full Approval from FDA to Commence Pivotal Study	PRICE SENSITIVE	30/10/12	93.05KB	Share
GID	Clinical Results on EndoBarrier Re-implantation	PRICE SENSITIVE	23/10/12	110.13KB	Share
GID	Key Hormones Affecting Satiety and Blood Sugar Control	PRICE SENSITIVE	23/10/12	113.59KB	Share
GID	Briefing Call and Webcast on Financial Results		22/10/12	68.01KB	Share
GID	New Voluntary Escrow Arrangements for Securities		04/10/12	63.82KB	Share
GID	EndoBarrier Therapy Offers Improved Glycemic Control		02/10/12	109.64KB	Share
GID	Appendix 3B		26/09/12	226.87KB	Share
GID	First Cases at St. Vincent's Clinic in Sydney, Australia	PRICE SENSITIVE	24/09/12	74.12KB	Share
GID	Appendix 3B		05/09/12	230.9KB	Share
GID	Half year financial accounts 30 June 2012	PRICE SENSITIVE	30/08/12	337.98KB	Share
GID	FDA Conditional Approval for Pivotal Clinical Trial	PRICE SENSITIVE	23/08/12	93.3KB	Share
GID	Release of Securities from Voluntary Escrow		21/08/12	88.44KB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/12	254.74KB	Share
GID	GI Dynamics, Inc. Announces Further Commercial Expansion	PRICE SENSITIVE	17/07/12	99.36KB	Share
GID	Appendix 3B		06/07/12	207.33KB	Share
GID	Clinical data on EndoBarrier Therapy for low BMI patients		25/06/12	137.73KB	Share
GID	GI Dynamics to Present at the Jefferies Healthcare Confer		04/06/12	63.47KB	Share
GID	Gore vs. GI Dynamics Lawsuit Summary Judgment Ruling	PRICE SENSITIVE	31/05/12	158.31KB	Share
GID	Appendix 3B		31/05/12	214.9KB	Share
GID	Results of Meeting		23/05/12	137.58KB	Share
GID	Annual General Meeting Presentation and Webcast		22/05/12	1.08MB	Share
GID	2012 AGM Access for Participants by Webcast/Conference Call		15/05/12	130.43KB	Share
GID	Appendix 3B		15/05/12	207.67KB	Share
GID	Appendix 3B		09/05/12	205.77KB	Share
GID	EndoBarrier Therapy Data Published in Annals of Surgery		02/05/12	136.77KB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/12	199.33KB	Share
GID	Proxy Statement and Notice of 2012 AGM		27/04/12	475.17KB	Share
GID	First Cases of EndoBarrier Therapy in Australia	PRICE SENSITIVE	19/04/12	67.14KB	Share

GIDAssociation of British Clinical Diabetologists Funds Study
09/09/13	PRICE SENSITIVE	103.49KB	Share
GIDHalf Yearly Report and Accounts
30/08/13	PRICE SENSITIVE	215.19KB	Share
GIDInformation disclosed under ASX Listing Rule 3.10.5A
30/08/13		34KB	Share
GIDRelease of Securities from ASX Escrow
22/08/13		31.51KB	Share
GIDChange in substantial holding
14/08/13		81.3KB	Share
GIDCeasing to be a substantial holder
13/08/13		50.31KB	Share
GIDChange in substantial holding
13/08/13		50.45KB	Share
GIDChange in substantial holding
13/08/13		50.67KB	Share
GIDChange in substantial holding
13/08/13		52.38KB	Share
GIDChange in substantial holding
13/08/13		53.97KB	Share
GIDCleansing Notice
09/08/13		504.24KB	Share
GIDAppendix 3B
09/08/13		168.6KB	Share
GIDGI Dynamics to Present at Canaccord Genuity Conference
08/08/13		54.86KB	Share
GIDChange of Director's Interest Notice
07/08/13		74.54KB	Share
GIDChange of Director's Interest Notice
07/08/13		74.55KB	Share
GIDAppendix 3B
07/08/13		225.73KB	Share
GIDForm604 Notice of change of interests of substantial holder
06/08/13		38.81KB	Share
GIDResults of Meeting
01/08/13		168.92KB	Share
GIDAppendix 4C - quarterly
31/07/13	PRICE SENSITIVE	168.6KB	Share
GIDSpecial Meeting of Stockholders Conference Call
24/07/13		44.92KB	Share
GIDSecurity Purchase Plan
12/07/13		626.31KB	Share
GIDNotice of Extraordinary General Meeting/Proxy Form
12/07/13		437.49KB	Share
GIDBecoming a substantial holder
12/07/13		145.11KB	Share
GIDAppendix 3B
11/07/13		188.34KB	Share
GIDForm604 Notice of change of interests of substantial holder
11/07/13		77.29KB	Share
GIDCleansing Notice
10/07/13		83.54KB	Share
GIDDetails of Company Address
05/07/13		48.96KB	Share
GIDGI Dynamics Investor Presentation
03/07/13		1.62MB	Share
GIDGI Dynamics Completes A$57.5 MIillion Private Placement
03/07/13	PRICE SENSITIVE	105.29KB	Share
GIDTrading Halt
01/07/13	PRICE SENSITIVE	485.72KB	Share
GIDGI Dynamics, Inc. Appoints Distributor for the Middle East
26/06/13	PRICE SENSITIVE	75.81KB	Share
GIDFrench Government Approves and Funds Two-Year Clinical Study
19/06/13	PRICE SENSITIVE	79.84KB	Share
GIDNew Commercial Centres in the European Union
18/06/13	PRICE SENSITIVE	80.18KB	Share
GIDAppendix 3B
06/06/13	PRICE SENSITIVE	172.12KB	Share
GIDResults of Meeting
20/05/13		139.65KB	Share
GIDAnnual General Meeting Presentation and Webcast
20/05/13		1.53MB	Share
GID2013 Annual General Meeting Webcast/Conference Call
14/05/13		89.98KB	Share
GIDGI Dynamics names David Maggs, M.D. as Chief Medical Officer
01/05/13		339.04KB	Share
GIDNotice of Annual Meeting/Proxy Form
30/04/13		1.14MB	Share
GIDAppendix 4C - quarterly
30/04/13	PRICE SENSITIVE	157.3KB	Share
GIDChange in substantial holding
26/04/13		85.57KB	Share
GIDGI Dynamics, Inc. Reports on Progress of the ENDO Trial
26/04/13	PRICE SENSITIVE	80.18KB	Share
GIDAppendix 3B
12/04/13		215.95KB	Share
GIDAnnual Report to shareholders
28/03/13		1.66MB	Share
GIDDetails of Company Address
28/03/13		38.2KB	Share
GIDChange of Directors Interest Notice
19/03/13		77.14KB	Share
GIDAppendix 3B
19/03/13		164.59KB	Share
GIDEndoBarrier Named Product of the Year by BioSpectrum Asia
18/03/13		45.07KB	Share
GIDChange of Director's Interest Notice
12/03/13		77.88KB	Share
GIDChange of Director's Interest Notice
12/03/13		76.18KB	Share
GIDCMS Medical to Distribute EndoBarrier Therapy in Brazil
06/03/13		72.54KB	Share
GIDPreliminary Final Report
28/02/13	PRICE SENSITIVE	568.96KB	Share
GIDCommercial Availability of EndoBarrier Therapy in Israel
27/02/13	PRICE SENSITIVE	97.93KB	Share
GIDGI Dynamics to Present at the Cowen Healthcare Conference
27/02/13		30.53KB	Share
GIDChange of Director's Interest Notice
26/02/13		76.08KB	Share
GIDChange of Director's Interest Notice
26/02/13		77.71KB	Share
GIDBriefing Call and Webcast on Financial Results for 2012
20/02/13		66.98KB	Share
GIDRelease of Securities from Voluntary Escrow
19/02/13		88.34KB	Share
GIDEndoBarrier Therapy effect on mildly obese patients
01/02/13	PRICE SENSITIVE	124.31KB	Share
GIDAppendix 4C - quarterly
30/01/13	PRICE SENSITIVE	196.75KB	Share
GIDAppendix 3B
18/01/13		232.07KB	Share
GIDU.S. Pivotal Clinical Trial of EndoBarrier Initiated
15/01/13	PRICE SENSITIVE	128.74KB	Share
GIDGI Dynamics Announces Resolution of Litigation with Gore
10/01/13	PRICE SENSITIVE	128.29KB	Share
GIDGI Dynamics Announces Research Collaborations
04/01/13	PRICE SENSITIVE	104.93KB	Share
GIDChange of Director's Interest Notice
19/12/12		74.73KB	Share
GIDForm604 Notice of Change of interests of substantial holder
03/12/12		62.43KB	Share
GIDRelease of Securities from Voluntary Escrow
27/11/12		88.18KB	Share
GIDAppendix 3B
22/11/12		233.78KB	Share
GIDGID to Present at Lazard and Canaccord Hlthcare Conferences
07/11/12		107.65KB	Share
GIDForm604 Notice of change of interests of substantial holder
02/11/12		71.02KB	Share
GIDForm604 Notice of change of Interests of substantial holder
01/11/12		70.58KB	Share
GIDAppendix 4C - quarterly
30/10/12	PRICE SENSITIVE	231.68KB	Share
GIDFull Approval from FDA to Commence Pivotal Study
30/10/12	PRICE SENSITIVE	93.05KB	Share
GIDClinical Results on EndoBarrier Re-implantation
23/10/12	PRICE SENSITIVE	110.13KB	Share
GIDKey Hormones Affecting Satiety and Blood Sugar Control
23/10/12	PRICE SENSITIVE	113.59KB	Share
GIDBriefing Call and Webcast on Financial Results
22/10/12		68.01KB	Share
GIDNew Voluntary Escrow Arrangements for Securities
04/10/12		63.82KB	Share
GIDEndoBarrier Therapy Offers Improved Glycemic Control
02/10/12		109.64KB	Share
GIDAppendix 3B
26/09/12		226.87KB	Share
GIDFirst Cases at St. Vincent's Clinic in Sydney, Australia
24/09/12	PRICE SENSITIVE	74.12KB	Share
GIDAppendix 3B
05/09/12		230.9KB	Share
GIDHalf year financial accounts 30 June 2012
30/08/12	PRICE SENSITIVE	337.98KB	Share
GIDFDA Conditional Approval for Pivotal Clinical Trial
23/08/12	PRICE SENSITIVE	93.3KB	Share
GIDRelease of Securities from Voluntary Escrow
21/08/12		88.44KB	Share
GIDAppendix 4C - quarterly
30/07/12	PRICE SENSITIVE	254.74KB	Share
GIDGI Dynamics, Inc. Announces Further Commercial Expansion
17/07/12	PRICE SENSITIVE	99.36KB	Share
GIDAppendix 3B
06/07/12		207.33KB	Share
GIDClinical data on EndoBarrier Therapy for low BMI patients
25/06/12		137.73KB	Share
GIDGI Dynamics to Present at the Jefferies Healthcare Confer
04/06/12		63.47KB	Share
GIDGore vs. GI Dynamics Lawsuit Summary Judgment Ruling
31/05/12	PRICE SENSITIVE	158.31KB	Share
GIDAppendix 3B
31/05/12		214.9KB	Share
GIDResults of Meeting
23/05/12		137.58KB	Share
GIDAnnual General Meeting Presentation and Webcast
22/05/12		1.08MB	Share
GID2012 AGM Access for Participants by Webcast/Conference Call
15/05/12		130.43KB	Share
GIDAppendix 3B
15/05/12		207.67KB	Share
GIDAppendix 3B
09/05/12		205.77KB	Share
GIDEndoBarrier Therapy Data Published in Annals of Surgery
02/05/12		136.77KB	Share
GIDAppendix 4C - quarterly
30/04/12	PRICE SENSITIVE	199.33KB	Share
GIDProxy Statement and Notice of 2012 AGM
27/04/12		475.17KB	Share
GIDFirst Cases of EndoBarrier Therapy in Australia
19/04/12	PRICE SENSITIVE	67.14KB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

GI DYNAMICS, INC - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available